Medicamen Organics Limited IPO

Apply 0
Avoid 0

This business is a pharmaceutical company specializing in the development, manufacturing, and distribution of a broad range of pharmaceutical dosage forms. These include tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders. They primarily operate as a contract manufacturer or third-party manufacturer, serving both governmental (state and central) and private institutions.

Manufacturing Capabilities:

i. The two WHO GMP-certified facilities are based in Haridwar, Uttarakhand, with an expansive area of over 21,500 square feet.
ii. These facilities feature a fully equipped quality control department with experienced staff, an in-house testing laboratory, and the necessary infrastructure to ensure the quality of both raw materials and finished products.
iii. ISO 9001:2015 certification ensures adherence to stringent quality management standards.

Product Portfolio:

i. The product portfolio comprises 84 products, spanning categories such as antibiotics, anti-diarrheals, antifungals, antimalarials, antidiabetics, proton pump inhibitors, antihistamines, antihypertensives, lipid regulators, antiparasitics, multivitamins, minerals, and NSAIDs.

Market Reach and Strategy:

i. They market their products through third-party distributors domestically and internationally, targeting private pharmaceutical companies and operating under a loan license.
ii. Their markets include India and a diverse international portfolio across Africa, CIS countries, and Southeast Asia. Countries like Congo, Burundi, the Philippines, Kenya, and Kyrgyzstan are among your primary markets.
iii. A recent direct export to Burundi reflects your strategic focus on establishing a direct international presence.

Business Model:
Their B2B model is primarily based on contract manufacturing, and their core competency lies in product development and documentation. This provides an advantage in market adaptability, frequent product launches, and competitive pricing.

With these foundational strengths, their business is poised for continued growth in the pharmaceutical industry, both in domestic and international markets.

Objects of the Medicamen Organics Limited IPO:

The Company proposes to utilize the Net Proceeds from the Issue towards the following objects: i. Funding of expenses proposed to be incurred towards Product registration in the international markets; ii. Plant updation and increase in production capacity; iii. Funding working capital requirements of our Company; iv. General Corporate Purposes.

Medicamen Organics Limited IPO Details:

Face Value: ₹ 10 Per Equity Share
Listing At: NSE Emerge

Promoters And Management:

Bal Kishan Gupta, Indian National, aged 71 years, is the Promoter of the Company. He is the Chairman and Managing Director of the Company. He holds a bachelor of Arts degree. He has more than 35 years of experience in manufacturing, exports and distribution of pharmaceutical products. He has been associated with the Company since inception and is responsible for expanding business horizons, corporate strategy, leadership and management, financial performance across verticals, stakeholder relations, innovation and growth, identifying new opportunities and risk management of the Company. He has been General Secretary of IDMA (India Drugs Manufactures Associations), it is the most reputed association in India for pharmaceutical manufactures. Ashutosh Gupta, Indian National, aged 43 years, is a Whole-time Director of the Company. He holds the degree of Bachelor of Business Administration from Guru Jambheshwar University, Hissar. He has been awarded with the degree of Honorary Doctorate in contribution in Export of Pharma Industry in the year 2021. He has been Chairman of Pharmexcil (Pharmaceuticals Export Promotion Council of India) from 2014-2016, a Government of India Council, specifically created for promotion of pharmaceutical exports from India. Shailesh Harimohan Gaur, Indian National, aged 55 years, is an Executive Director of the Company. He holds the degree of Bachelor of Science and Master of Business Administration (MBA) awarded by National Institute of Business Management. He has undergone Diploma programme in Production Management. He has a vast experience of more than 33 years in pharmaceutical manufacturing, pharmaceutical projects, installation, validations, Research and Development of different pharmaceutical formulations. His current key functional areas are Production Planning and Inventory Control (PPIC), various audits etc.

Financials of Medicamen Organics Limited IPO:

To be updated shortly.

Comparison With Peers:

To be updated shortly.

Recommendation on Medicamen Organics Limited IPO:

To be updated shortly.

Lead Manager of Medicamen Organics Limited IPO:


Registrar of Medicamen Organics Limited IPO:

  1. Kfin Technology Private Limited

Discussion on Medicamen Organics Limited IPO:

Leave a Reply